(Q35164736)

6 August 2017

1 reference

title

Novel approaches in the treatment of ankylosing spondylitis and other spondyloarthritides (English)

1 reference

6 August 2017

main subject

ankylosing spondylitis

1 reference

based on heuristic

inferred from title

author

Désirée van der Heijde

series ordinal

2

object named as

Désirée van der Heijde

0 references

author name string

Juergen Braun

series ordinal

1

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

Expert Opinion on Investigational Drugs

6 August 2017

published in

1 reference

6 August 2017

volume

12

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

1097-1109

1 reference

Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging: many, but not all patients with sacroiliitis have spondyloarthropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Employment perspectives of patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Prognosis, course of disease, and treatment of the spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Ankylosing spondylitis: what is the cost to society, and can it be reduced?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Enthesitis and ankylosis in spondyloarthropathy: what is the target of the immune response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Immunohistological study of entheses in spondyloarthropathies: comparison in rheumatoid arthritis and osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis- cellularity correlates with the degree of enhancement detected by magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Is infliximab effective for induction of remission in patients with ulcerative colitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Tumour necrosis factor (TNF) in psoriatic arthritis: pathophysiology and treatment with TNF inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Role of novel biological therapies in psoriatic arthritis: effects on joints and skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Radiologic diagnosis and pathology of the spondyloarthropathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Etanercept therapy in children with treatment-resistant uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Successful use of infliximab in a patient with treatment resistant spondyloarthropathy related uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Atopic disorders in ankylosing spondylitis and rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Immunity to the G1 globular domain of the cartilage proteoglycan aggrecan can induce inflammatory erosive polyarthritis and spondylitis in BALB/c mice but immunity to G1 is inhibited by covalently bound keratan sulfate in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

Pharmacogenetic investigation of the TNF/TNF-receptor system in patients with chronic active Crohn's disease treated with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.12.7.1097

10.1517/13543784.12.7.1097

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference